Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers
Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis